Interestingly, applying the same analysis to ER+ breast cancer, we found only a much smaller number (193) of negative kurtosis profiles (Additional data file 2), despite there being roughly twice as many bimodal profiles in ER+ breast cancer (about 4500 in ER+ versus about 2,500 in ER-). This evidence concerns the gene ESR1 and breast carcinoma.